Navigation Links
Applied Protein Sciences Acquired by IndUS Pharmaceuticals
Date:6/10/2013

Mountain View, CA (PRWEB) June 10, 2013

Applied Protein Sciences (APS), a privately held biotech company founded in 2007 in Mountain View, CA, announces that it has been acquired by IndUS Pharmaceuticals (IndUS), a privately held Boston based pharmaceutical company.

The acquisition gives IndUS the ability to extend its pipeline to include preclinical stage molecules for the treatment of Oral Mucositis, a severe unmet medical need for cancer patients. APS has shown significant efficacy in the prevention and treatment of oral mucositis (OM) in several animal models. Specifically, APS demonstrated a 45% reduction in the number of cases of severe and moderate mucositis, which translates to significantly lower hospitalization rates. The preclinical candidates also have potential for the treatment of unmet medical needs such as GI mucositis, inflammatory bowel disease (IBD) and proctitis. APS drug molecules, their use and synthesis is protected by an extensive patent portfolio, including currently 6 issued US patents.

Aman Johar, co-founder of APS said, “APS preclinical candidates have shown the potential to make cancer treatments more effective and IndUS is the right partner to take the drug candidates through the development cycle.” Funding for the pre-clinical studies was provided by Innovation Management Sciences (IMSciences), a private investment firm that specializes in technology companies with strong intellectual property portfolios. Pravin Chaturvedi, CEO of IndUS said “the addition of these molecules provides IndUS with an exciting opportunity to develop and commercialize novel oral mucositis treatments to address acute unmet medical needs in cancer radiation and/or chemotherapy.”

IndUS and its Indian affiliate Sindu Research Laboratories Private Limited, a drug discovery company, are developing several novel pyrrolobenzodiazepine dimers (PBDs) for the treatment of various hematologic and solid cancers. IndUS also has exclusive access to evaluate and license new chemical entities (NCEs) discovered in premier research institutes in India for use in the treatment of cancer, diabetes and infectious diseases.

For more information please visit: http://www.induspharm.com and http://www.appliedprotein.com

Read the full story at http://www.prweb.com/releases/AppliedProtein/IndUS/prweb10797440.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Applied nanobiomedicine: Exploiting nanoparticles to hunt for hidden cancer cells
2. To Meet Growing Demand for Sports Psychology Experts, Wexford University Offers Master’s Degree in Applied Sport Psychology: Classes Begin April 1
3. Spring Classes for Wexford University’s Online Doctoral Degree in Applied Sport Psychology Begin April 1
4. New Research Says Topically Applied L-Carnitine Effective in Treating Oily Skin
5. Fourth Annual Georgia Partnership for Telehealth, Inc. Conference, Impacting Lives Through Applied Technology, to be held March 18-20th 2013 in Savannah, Georgia
6. Wexford University Spring Classes for Online Doctoral Degree in Applied Sport Psychology Begin April 1
7. John Mitchell Re-Joins Applied Marketing Science
8. Charity Navigator Awards the Mesothelioma Applied Research Foundation with 4-Star Rating
9. The Mesothelioma Applied Research Foundation Opened its 2013 Grant Cycle
10. Applied Research Associates Remembers Tim Samaras
11. Warwick scientists uncover how checkpoint proteins bind chromosomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work ... as “patient engagement.” The patient is doing more than filling out a survey; in ... “There is an increasing emphasis in health care and research on the importance of ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and ... Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD ... that can be easily incorporated into liquid products, while reducing costs to end users. ...
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- AllianceRx Walgreens Prime, the combined central specialty pharmacy and ... manager Prime Therapeutics LLC (Prime), today officially began the ... of new signage at its headquarters in ... few other company-owned facilities across the country. This also ... whom will begin to see the AllianceRx Walgreens Prime ...
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans ... advance the use of wearable and home sensors for ... disorders. Early Signal Foundation, a nonprofit organization focused on ... will provide an affordable analytical system to record and ... ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
Breaking Medicine Technology: